Dr. Jemima Frimpong, PhD

Claim this profile
Studies Hepatitis
Studies Substance Addiction
1 reported clinical trial
3 drugs studied

Clinical Trials Jemima Frimpong, PhD is currently running

Image of trial facility.

HIV/HCV Testing

for Substance Use Disorder

This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment. Aims are: Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing. Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care. Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition. Primary Hypothesis: 1. The two PC interventions will result in significantly higher proportions of patients tested for HIV than the information control condition during the "initial impact" period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Primary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary). 2. The HIV/HCV PC intervention will result in significantly higher proportions of patients tested for HIV than the HIV PC intervention during the initial impact period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Secondary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary).
Recruiting1 award N/A

More about Jemima Frimpong, PhD

Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Jemima Frimpong, PhD has experience with
  • HIV And HCV Testing Practice Coaching Intervention
  • HIV Testing Practice Coaching Intervention
  • Information Control

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jemima Frimpong, PhD specialize in?
Jemima Frimpong, PhD focuses on Hepatitis and Substance Addiction. In particular, much of their work with Hepatitis has involved treating patients, or patients who are undergoing treatment.
Is Jemima Frimpong, PhD currently recruiting for clinical trials?
Yes, Jemima Frimpong, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Jemima Frimpong, PhD has studied deeply?
Yes, Jemima Frimpong, PhD has studied treatments such as HIV and HCV Testing Practice Coaching Intervention, HIV Testing Practice Coaching Intervention, Information Control.
What is the best way to schedule an appointment with Jemima Frimpong, PhD?
Apply for one of the trials that Jemima Frimpong, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.